Consensus Walvax Biotechnology Co., Ltd.

Equities

End-of-day quote Shenzhen S.E. Other stock markets 06:00:00 2024-04-25 pm EDT			5-day change	1st Jan Change
14.33 ^CNY	+3.54%		+2.43%	-39.05%

Apr. 26	Walvax Biotechnology's Profit Drops 92%, Operating Income Slids 28% in Q1 2024	MT
Apr. 25	Walvax Biotechnology's Unit to End COVID-19 Vaccine Trial	MT

7c.AWteMdAZaUbHFJBB7SeEypS1ypI5XSpXVu7JazfB5PU.QiInc6dhI3a_JvQthWDc56L7jupQF24AEaWsGn-EtsxVOAZjul8iDLBl3Q~be2eebac069777fa781000ed949267a3

Walvax Biotechnology Scraps Plan to Issue Convertible Bonds	Apr. 01	MT
China's potential mRNA COVID vaccine weaker against Omicron-study	22-02-15	RE

Sell

Buy

Mean consensus

HOLD

Number of Analysts

Last Close Price

14.33 CNY

Average target price

20 CNY

Spread / Average Target

+39.57%

High Price Target

25 CNY

Spread / Highest target

+74.46%

Low Price Target

15 CNY

Spread / Lowest Target

+4.68%

Trading Rating

Investor Rating

ESG Refinitiv

C+